Zepbound 5 MG/0.5 ML pen 0.5ML
Ended Awarded Last action
- Contract number
- SPE2DR26FFL4M
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $10,465
Award facts
- Contract value 100% obligated
- $10,464.66 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $10,464.66 to AmerisourceBergen Drug Corp for the supply of Zepbound 5 mg/0.5 mL pens on January 26, 2026. This is a firm fixed-price order with an ultimate completion date of January 27, 2026, and represents a non-set-aside competitive award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the delivery at its corporate office location. This delivery order is issued under AmerisourceBergen's significant Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), which is valued at $999,999,999 and extends through December 2026, serving as a comprehensive global pharmaceutical support vehicle for military healthcare programs.
AmerisourceBergen operates as a subsidiary of Cencora, Inc., a major pharmaceutical distributor and healthcare solutions provider that serves as a critical vendor for federal medical procurement needs across the Department of Defense and other government agencies. The parent company holds an even larger IDC with DLA valued at up to $999,999,999 through December 31, 2031. This Zepbound delivery order reflects AmerisourceBergen's ongoing role in supplying pharmaceutical products to support military and veteran healthcare systems, with Zepbound being a diabetes medication used within the broader portfolio of prescription and specialty medications delivered under these federal contract vehicles.
Quick answers
Who was awarded contract SPE2DR26FFL4M?
SPE2DR26FFL4M was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 26, 2026.
How much is contract SPE2DR26FFL4M worth?
The government has obligated $10,465 on SPE2DR26FFL4M.
Is contract SPE2DR26FFL4M an order under another contract?
Yes. SPE2DR26FFL4M is a delivery order under SPE2DR25D1109, an indefinite delivery contract.
Was contract SPE2DR26FFL4M competed?
The extent of competition for SPE2DR26FFL4M was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award